Short form of the heparin-binding EGF-like growth factor: Communication II
โ Scribed by E. V. Loukianov; Yu. V. Kozlov
- Book ID
- 110174386
- Publisher
- SP MAIK Nauka/Interperiodica
- Year
- 2006
- Tongue
- English
- Weight
- 242 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0026-8933
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Heparinโbinding EGFโlike growth factor (HBโEGF), which belongs to the EGFโfamily of growth factors, was isolated from the conditioned medium of macrophageโlike cells. To investigate the effect of __N__โ and __C__โterminal residues of the EGFโlike domain of HBโEGF in the binding affinity
Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) is a member of the EGF family and is highly expressed in hepatoma tissues but not in normal liver. However, it is unknown when HB-EGF is induced during hepatocarcinogenesis and what are the mechanisms underlying its high expre
Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) is a member of the EGF family of polypeptide growth factors, which includes EGF, transforming growth faaor a (TGF-a), amphiregulin (AR) and betacellulin (BTC). To assess the potential role of HB-EGF in human gastric carcinomas
Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases. Inhibition of BCR-ABL and c-kit accounts for its clinical activity in leukemia and sarcoma, respectively. In this report, we describe other cellular targets for imatinib.